跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36,863 条关于
“TCG Crossover Management”
全部
36,863
临床试验
27,298
药物
892
机构
223
资讯
8,450
10个月前
Liquidia's YUTREPIA Achieves Commercial Success with $51.7M Q3 Sales, Attracting Major Biotech Fund Investment
去年
Indena and TCG GreenChem Form Strategic Alliance to Accelerate ADC Payload-Linker Development
去年
TCG Labs Soleil Raises $400M to Build Single-Asset Biotech Startups for Strategic Partnerships
4年前
Arbor Biotechnologies Secures $215M Series B to Advance CRISPR Gene Editing Platform
去年
Long-Term Follow-Up of TRANSFORM Trial Shows Sustained Benefits of Liso-Cel CAR T-Cell Therapy in Relapsed LBCL
2个月前
TriMaster Crossover Trial Shows Routine Clinical Data May Outperform Diabetes Subtypes for Precision Prescribing
去年
Juri Biosciences Secures Global Rights to KLK2-Targeted T-Cell Engager for Metastatic Prostate Cancer in $210M Deal
4个月前
Abivax Repurchases $90 Million in Royalty Certificates, Streamlining Capital Structure Ahead of Obefazimod Commercialization
4个月前
Accro Bioscience Secures $50M Series C to Advance RIPK2 Inhibitor AC-101 for Ulcerative Colitis
2年前
Tirzepatide (Mounjaro) Approved in Australia for Weight Management in Comorbid Adults
第 1 页,共 845 页
上一页
下一页